Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Angiogenesis ; 17(1): 93-107, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23982332

RESUMO

In the past two decades advances in the development of targeted nanoparticles have facilitated their application as molecular imaging agents and targeted drug delivery vehicles. Nanoparticle-enhanced molecular imaging of the angiogenic tumor vasculature has been of particular interest. Not only because angiogenesis plays an important role in various pathologies, but also since endothelial cell surface receptors are directly accessible for relatively large circulating nanoparticles. Typically, nanoparticle targeting towards these receptors is studied by analyzing the contrast distribution on tumor images acquired before and at set time points after administration. Although several exciting proof-of-concept studies demonstrated qualitative assessment of relative target concentration and distribution, these studies did not provide quantitative information on the nanoparticle targeting kinetics. These kinetics will not only depend on nanoparticle characteristics, but also on receptor binding and recycling. In this study, we monitored the in vivo targeting kinetics of αvß3-integrin specific nanoparticles with intravital microscopy and dynamic contrast enhanced magnetic resonance imaging, and using compartment modeling we were able to quantify nanoparticle targeting rates. As such, this approach can facilitate optimization of targeted nanoparticle design and it holds promise for providing more quantitative information on in vivo receptor levels. Interestingly, we also observed a periodicity in the accumulation kinetics of αvß3-integrin targeted nanoparticles and hypothesize that this periodicity is caused by receptor binding, internalization and recycling dynamics. Taken together, this demonstrates that our experimental approach provides new insights in in vivo nanoparticle targeting, which may proof useful for vascular targeting in general.


Assuntos
Meios de Contraste , Sistemas de Liberação de Medicamentos , Integrina alfaVbeta3 , Angiografia por Ressonância Magnética/métodos , Nanopartículas/química , Neovascularização Patológica/diagnóstico por imagem , Neoplasias Ovarianas/irrigação sanguínea , Neoplasias Ovarianas/diagnóstico por imagem , Animais , Meios de Contraste/química , Meios de Contraste/farmacologia , Feminino , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Neovascularização Patológica/metabolismo , Neoplasias Ovarianas/metabolismo , Radiografia
2.
Ultrasound Med Biol ; 39(7): 1255-66, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23643054

RESUMO

Combining liposomally encapsulated cytotoxic drugs with ultrasound exposure has improved the therapeutic response to cancer in animal models; however, little is known about the underlying mechanisms. This study focused on investigating the effect of ultrasound exposures (1 MHz and 300 kHz) on the delivery and distribution of liposomal doxorubicin in mice with prostate cancer xenografts. The mice were exposed to ultrasound 24 h after liposome administration to study the effect on release of doxorubicin and its penetration through the extracellular matrix. Optical imaging methods were used to examine the effects at both microscopic subcellular and macroscopic tissue levels. Confocal laser scanning microscopy revealed that ultrasound-exposed tumors had increased levels of released doxorubicin compared with unexposed control tumors and that the distribution of liposomes and doxorubicin through the tumor tissue was improved. Whole-animal optical imaging revealed that liposomes were taken up by both abdominal organs and tumors.


Assuntos
Doxorrubicina/análogos & derivados , Eletroporação/métodos , Taxa de Depuração Metabólica/efeitos da radiação , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/metabolismo , Sonicação/métodos , Animais , Antibióticos Antineoplásicos/administração & dosagem , Antibióticos Antineoplásicos/farmacocinética , Linhagem Celular Tumoral , Doxorrubicina/administração & dosagem , Doxorrubicina/farmacocinética , Feminino , Humanos , Masculino , Camundongos Endogâmicos BALB C , Camundongos Nus , Polietilenoglicóis/administração & dosagem , Polietilenoglicóis/farmacocinética , Neoplasias da Próstata/patologia , Distribuição Tecidual/efeitos da radiação , Resultado do Tratamento , Terapia por Ultrassom/métodos
3.
Int J Biol Macromol ; 51(5): 1043-51, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22947453

RESUMO

The success of gene therapy depends on efficient delivery of DNA and requires a vector. A promising non-viral vector is chitosan. We tailored chitosan to optimize it for transfection by synthesizing self-branched and trisaccharide-substituted chitosan oligomers (SBTCO), which show superior transfection efficacy compared with linear chitosan (LCO). The aim of the work was to compare the cellular uptake and endocytic pathways of polyplexes formed by LCO and SBTCO. Both polyplexes were taken up by the majority of the cells, but the uptake of LCO was lower than SBTCO polyplexes. LCO polyplexes were internalized through both clathrin-dependent and clathrin-independent pathways, whereas SBTCO polyplexes were primarily taken up by clathrin-independent endocytosis. The different level of cellular uptake and the distinct endocytic pathways, may explain the difference in transfection efficacy. This was supported by the observation that photochemical internalization increased the transfection by LCO polyplexes considerably, whereas no effect on transfection was found for SBTCO polyplexes.


Assuntos
Cavéolas/metabolismo , Quitosana/química , Quitosana/metabolismo , Clatrina/metabolismo , DNA/metabolismo , Endocitose , Nanopartículas , Cavéolas/efeitos dos fármacos , Clorpromazina/farmacologia , DNA/genética , Portadores de Fármacos/química , Portadores de Fármacos/metabolismo , Endocitose/efeitos dos fármacos , Genisteína/farmacologia , Células HeLa , Humanos , Hidrazonas/farmacologia , Propriedades de Superfície , Temperatura , Transfecção
4.
Ultrasound Med Biol ; 38(3): 476-86, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22264409

RESUMO

The ultrasound exposure parameters that maximize drug release from dierucoyl-phosphatidylcholine (DEPC)-based liposomes were studied using two transducers operating at 300 kHz and 1 MHz. Fluorescent calcein was used as a model drug, and the release from liposomes in solution was measured using a spectrophotometer. The release of calcein was more efficient at 300 kHz than at 1 MHz, with thresholds of peak negative pressures of 0.9 MPa and 1.9 MPa, respectively. Above this threshold, the release increased with increasing peak negative pressure, mechanical index (MI), and duty cycle. The amount of drug released followed first-order kinetics and increased with exposure time to a maximal release. To increase the release further, the MI had to be increased. The results demonstrate that the MI and the overall exposure time are the major parameters that determine the drug's release. The drug's release is probably due to mechanical (cavitation) rather than thermal effects, and that was also confirmed by the detection of hydroxide radicals.


Assuntos
Preparações de Ação Retardada/química , Preparações de Ação Retardada/efeitos da radiação , Fluoresceínas/química , Lipossomos/química , Lipossomos/efeitos da radiação , Sonicação/métodos , Difusão/efeitos da radiação , Relação Dose-Resposta à Radiação , Fluoresceínas/efeitos da radiação , Doses de Radiação
5.
Anticancer Res ; 27(3B): 1475-81, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17595764

RESUMO

BACKGROUND: Collagenase and hyaluronidase are enzymes which degrade the extracellular matrix and increase the uptake and improve the distribution of therapeutic macromolecules in tumours. The purpose of the present work was to investigate whether collagenase or hyaluronidase had any effects on transient perfusion and/or changes in vascular areas. MATERIALS AND METHODS: The effects were studied in human osteosarcomas in BALB/c nu/nu mice growing orthotopically around and infiltrating the femurs, and in dorsal skinfold chambers using confocal laser scanning microscopy. RESULTS: Both collagenase and hyaluronidase reduced the number of vessels that closed, but only collagenase increased the number of vessels which opened up, i.e. both enzymes improved the perfusion but collagenase to a greater extent than hyaluronidase. CONCLUSION: Destroying the structural protein network seems to be more efficient than degrading the gel of hyaluronan with respect to increase perfusion.


Assuntos
Neoplasias Ósseas/irrigação sanguínea , Colagenases/farmacologia , Hialuronoglucosaminidase/farmacologia , Osteossarcoma/irrigação sanguínea , Animais , Capilares/efeitos dos fármacos , Capilares/ultraestrutura , Feminino , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Microscopia Confocal , Perfusão , Fluxo Sanguíneo Regional/efeitos dos fármacos , Ensaios Antitumorais Modelo de Xenoenxerto
6.
Cancer Res ; 64(2): 547-53, 2004 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-14744768

RESUMO

Liposomal drug delivery appears to improve the antitumor effect and reduce toxicity compared with the free drug. The therapeutic index may be improved further by combining cytotoxic drugs and radiotherapy. Successful therapy requires that the cytotoxic agents reach the tumor cells. Therefore, we studied tumor growth and the microdistribution of liposomal doxorubicin (Caelyx) with and without additional ionizing radiation in human osteosarcoma xenografts in athymic mice. Caelyx was injected i.v. 1 day before single or fractionated radiotherapy. Both chemoirradiation regimens induced significant tumor growth delays and worked synergistically. Confocal laser scanning microscopy showed that intact liposomes were located in close proximity to endothelial cells, and the distribution of released doxorubicin was heterogeneous. Before radiotherapy, hardly any doxorubicin was localized in the central parts of the tumor. Radiotherapy increased the tumor uptake of doxorubicin by a factor of two to four, with drug being redistributed farther from the vessels in the tumor periphery and located around vessels in the central parts of the tumor. Colocalization of doxorubicin and hypoxic cells showed no distribution of drug into hypoxic areas. Dynamic contrast-enhanced magnetic resonance imaging (MRI) 1 day before the injection of Caelyx and 2 days after treatment start showed that the combined treatment reduced the vascular volume and the vascular transfer rate of the MRI tracer. The results show that chemoirradiation with Caelyx induces synergistic treatment effects. Improved intratumoral drug uptake and distribution are responsible to some extent for the enhanced antitumor effect.


Assuntos
Antibióticos Antineoplásicos/farmacocinética , Antibióticos Antineoplásicos/uso terapêutico , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/radioterapia , Doxorrubicina/farmacocinética , Doxorrubicina/uso terapêutico , Osteossarcoma/tratamento farmacológico , Osteossarcoma/radioterapia , Animais , Antibióticos Antineoplásicos/administração & dosagem , Linhagem Celular Tumoral , Terapia Combinada , Doxorrubicina/administração & dosagem , Portadores de Fármacos , Feminino , Humanos , Lipossomos , Camundongos , Camundongos Endogâmicos BALB C , Distribuição Tecidual , Transplante Heterólogo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...